Seven of these retreated lupus nephritis patients (7/17) had early retreatment, i.e. within 18 months from the nephritis flare for which RTX was started, two for non-nephritic flares (one ADA-positive and one ADA-negative) and five for nephritic flares (four of which ADA-positive), respectively. This evidence concerns the gene ADA and lupus nephritis.